Neuron navigator 3 Activators
Neuron navigator 3 Activators encompass a suite of chemical compounds that amplify the functional activity of Neuron navigator 3 through distinct signaling pathways, crucial for neuronal development and guidance. Forskolin, by increasing intracellular cAMP levels, indirectly bolsters the functional role of Neuron navigator 3 by facilitating PKA activation, which can phosphorylate substrates central to neurite outgrowth-a process where Neuron navigator 3 is pivotal. PMA, through PKC activation, enhances Neuron navigator 3 signaling pathways that are integral to neural guidance and growth cone dynamics. Sphingosine-1-phosphate, by triggering its receptors, can lead to actin reorganization, augmenting Neuron navigator 3's role in cytoskeletal dynamics, while ionomycin raises intracellular calcium, activating kinases that may influence Neuron navigator 3-mediated pathfinding. Rolipram and 5-Iodotubercidin, by increasing cAMP, and K252a, through selective PKC isoform inhibition, offer indirect pathways to amplify Neuron navigator 3's involvement in neuronal signaling and maturation.
Further, the analog db-cAMP provides sustained PKA stimulation, potentially enhancing Neuron navigator 3-dependent neuronal signaling and plasticity. LY294002, a PI3K inhibitor, indirectly potentiates Neuron navigator 3 activity by modulating compensatory pathways involved in cell growth, while Gö 6983 inhibits PKC isoforms that may downregulate Neuron navigator 3-relevant pathways, thus promoting its signaling role in neural differentiation. Anisomycin, as a JNK activator, may promote transcriptional changes that enhance Neuron navigator 3 activity, supporting cytoskeletal rearrangement and neuronal polarity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels in the cell. Elevated cAMP activates PKA (Protein Kinase A), which can phosphorylate various substrates. Since Neuron navigator 3 is involved in neuronal development, PKA phosphorylation can enhance the signaling pathways that promote neurite outgrowth where Neuron navigator 3 may play a role. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which is involved in numerous cellular signaling pathways, including those that govern neural development and cytoskeletal organization. PKC activation can, therefore, enhance the activity of Neuron navigator 3 in signaling pathways that are critical for neuronal guidance and growth cone dynamics. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which can lead to actin cytoskeleton reorganization. Since Neuron navigator 3 is implicated in cytoskeletal dynamics, sphingosine-1-phosphate can enhance the activity of Neuron navigator 3 in promoting cytoskeletal changes essential for neuronal development. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. Neuron navigator 3, being associated with neuronal pathfinding, may have its function enhanced through the activation of calcium-dependent protein kinases that modulate cytoskeletal organization. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which degrades cAMP. By inhibiting PDE4, rolipram leads to increased cAMP levels, thereby enhancing PKA activity. PKA can modulate various proteins involved in neuronal growth, potentially enhancing the functional activity of Neuron navigator 3 in neuronal signaling pathways. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
This adenosine kinase inhibitor leads to increased levels of adenosine, which can activate adenosine receptors and subsequent cAMP production. The elevated cAMP can enhance PKA activity, which may then phosphorylate targets that modulate the function of Neuron navigator 3, thus enhancing its activity in neuronal signaling and development. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
K252a is an indolocarbazole that is a potent inhibitor of protein kinase C (PKC). While it is broadly an inhibitor, it can selectively enhance the activity of Neuron navigator 3 through the inhibition of specific PKC isoforms that may negatively regulate pathways in which Neuron navigator 3 is involved, particularly in neuronal differentiation and axon guidance. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that readily diffuses into cells and resists enzymatic degradation, leading to sustained PKA activation. This activation can enhance the pathways in which Neuron navigator 3 functions, particularly those related to neuronal signaling and plasticity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K), which indirectly can enhance Neuron navigator 3 activity by modulating the PI3K/Akt pathway, often involved in cell survival and growth. Inhibition of PI3K can lead to a compensatory upregulation of alternate pathways that may involve Neuron navigator 3, thereby enhancing its functional role in neuronal development. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a pan-PKC inhibitor that can enhance Neuron navigator 3 activity indirectly by inhibiting PKC isoforms that may negatively regulate pathways involving Neuron navigator 3. By inhibiting negative regulatory mechanisms, Gö 6983 could potentiate the signaling pathways that are positively influenced by Neuron navigator 3, especially in the context of neural differentiation and guidance. | ||||||